Search
Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.
News
02 November 2023
Nine years after the draft version was published, the Food and Drug Administration (FDA) has finalized its guidance on informed consent for sponsors, institutions, IRBs, and investigators....
News
12 October 2023
Welcome to Hogan Lovells’ The Data Chronicles, brought to you by the firm’s global Privacy and Cybersecurity practice. This multimedia series is dedicated to the ever-changing...
News
11 October 2023
Last week, the U.S. Department of Health and Human Services (HHS) Office of Research Integrity (ORI) made the announcement many academic institutions, legal professionals, and observers in...
News
06 October 2023
Welcome to Hogan Lovells’ The Data Chronicles, brought to you by the firm’s global Privacy and Cybersecurity practice. This multimedia series is dedicated to the ever-changing...
News
05 October 2023
In a landmark proposed rule published Friday, the U.S. Food and Drug Administration (FDA) announced plans to make explicit that in vitro diagnostic products (IVDs), including in cases where ...
News
04 October 2023
In a landmark proposed rule published Friday, the U.S. Food and Drug Administration (FDA) announced plans to make explicit that in vitro diagnostic products (IVDs), including in cases where ...
News
18 September 2023
The U.S. Department of Labor (DOL) has proposed to substantially raise the pay thresholds that must be met for employees to be classified as exempt from overtime under the Fair Labor...
Media Mention
18 September 2023
Partner John Beckman, head of our U.S. Securities and Public Company Advisory practice, was quoted in an article by The National Law Journal discussing how the SEC’s proposed supply...
Hogan Lovells Publications
July 2023
Our 9th edition of the Hogan Lovells Guide on Internal Investigations in Germany will help you manage your legal risks in the field of compliance and internal investigations.
